Dates of Interest

Apr 24
Towards regulatory convergence and reliance
...
010-Programa-Sesion-Regulatoria-1.pdf
Apr 26
Challenging existing paradigms in the therapy of cancer
...
Apr 26
Incorporation of cyber resilience in the Operations area.
...
Apr 26
Cybersecurity
...
Apr 26
The Power of Linux as Digital Transformation
...
Apr 26
Experiences of integration of clinical systems through standards with open technologies.
...
Apr 26
SCADA system for electricity supply in the National Center for Biopreparations
...
Apr 26
Design of an automated system for critical supplies of a Quality Control laboratory in the biopharmaceutical industry.
...
Apr 26
Mejoras en el sistema automático de monitoreo continuo de partículas en áreas limpias de las Plantas de Parenterales de BIOCEN
...
Apr 26
Improvements in the automatic system for continuous monitoring of particles in clean areas of the BIOCEN Parenteral Plants.
...
Apr 26
Desafiando los paradigmas existentes en la terapia del cáncer
...
Apr 26
First steps in Industry 4.0 of Suma technology
...
Apr 26
IncuBIO: A Special Purpose Vehicle to funnel venture capital investment into Cuban biotech assets.
...
Apr 26
High Tech Joint Venture Enterprise for the Grain Seed Production.
...
Apr 26
National Design and implementation of an electronic prescription system in Belgium
...
Apr 26
Potential for the application of telemedicine in the export of cuban medical services. The case of the medical mission in Qatar
...
Apr 26
“Improving down-stream protein production.”
...
Apr 26
“Process Control of Continuous Bioprocesses”
...
Apr 26
Development and industrial scale-up of the first conjugate vaccine against SARS-CoV-2: Soberana 02
...
Apr 27
The senescent immune system as a key driver of aging
...
Apr 27
Cell senescence as a driver of chronic inflammation in ageing
...
Apr 27
Global virus outbreaks: interferons- as first line therapeutics
...
Apr 27
Interferon-gamma: When a good cytokine goes bad
...
Apr 27
Itolizumab in the treatment of patients with COVID-19: Cuban experience
...
Apr 27
How the past can determine your future: can we reverse the epigenetic clock age to promote healthy aging?
...
Apr 27
Structural biology for vaccine development: the example of SOBERANA vaccines
...
Apr 27
Targeting senescence for healthy aging
...
Apr 27
Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children
...
Apr 27
Vaccination of convalescent children: Open label phase I/II clinical trial with a single doses of SOBERANA Plus
...
Apr 27
Anti-aging effect of Cuban policosanol via enhancement of anti-inflammatory effect in high-density lipoproteins
...
Apr 27
Molecular mechanisms of dietary restriction promoting health and longevity
...
Apr 27
Vulnerability management in OT environments.
...
Apr 27
Smart Company: Business automation for climated-based energy savings.
...
Apr 27
IC NEURONIC S.L. Experience in the production and certification of medical devices in Europe.
...
Apr 27
“CHO cell line engineering using  mirna and rapid screening of high producing clones”
...
Apr 27
“Magnetic bioseparation, biotechnological industry processes and nanoparticles as separation supports”
...
Apr 27
“Magnetic bioseparation, biotechnological industry processes and nanoparticles as separation supports”
...
Apr 27
Posibilities of early detection of tumors through bioimpedance measurements
...
Apr 28
Obesity accelerates age-associated human B cell defects: role of the adipose tissue
...
Apr 28
Efficacy and Preclinical Safety of vaccine candidates to SARS-CoV-2 (SOBERANA® Vaccines)
...
Apr 28
Chimeric antigen produced in HEK-293 cells, based on SARS-CoV2 nucleoprotein fused to the extracellular domain of human CD154, induced high immunogenicity in mice and non-human primates
...
Apr 28
Targeting of protein kinase CK2 in Acute Myeloid leukemia cells using the Clinical-Grade synthetic-peptide CIGB-300
...
Apr 28
Abexol: anti-inflammatory of natural origin for the management of symptoms in patients with osteoarthritis
...
Apr 28
Abdala vaccine against SARS-CoV-2 induces functional antibodies in rats and cynomolgus monkeys
...
Apr 28
Longitudinal study of the immune response generated against SARS-CoV-2 infection in Cuban COVID-19 recovered patients
...
Apr 28
BioManguinhos-BioCubaFarma Alliance: Successful experience in South-South collaboration in biotechnology.
...
Apr 28
CIM-CIMAB Alliance, thirty years of commercial experiences.
...
Apr 28
Cybersecurity
...
Apr 28
Quality 4 and its potential impact on the Cuban biotechnological, pharmaceutical and medical technology industry
...
Apr 28
Technology transfer and scaling of the production of biotechnological products and vaccines against COVID-19 in BioCen.
...
Apr 28
Proposal for the evaluation of transversal skills in the management of the software process from the Computer Sciences.
...
Apr 29
Immune Ageing: Focus on Sicilian ultra-centenarians
...
Apr 29
Implications of Immunosenescence for Immunization of Older Adults
...
Apr 29
Analysis of the landscape of medicines for the treatment of diseases of the elderly in Russia and the prospects for their increase
...
Apr 29
Association of chronic neurological diseases with clinical phenotypes of patients with COVID-19 in intensive care units
...
Apr 29
Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study
...
Apr 29
Evaluation and use of UMELISA SARS-CoV-2 ANTI RBD in immunogenicity studies of individuals immunized with the Abdala and Soberana vaccines
...
Apr 24
Towards regulatory convergence and reliance
...
010-Programa-Sesion-Regulatoria-1.pdf
Apr 26
Challenging existing paradigms in the therapy of cancer
...
Apr 26
Incorporation of cyber resilience in the Operations area.
...
Apr 26
Cybersecurity
...
Apr 26
The Power of Linux as Digital Transformation
...
Apr 26
Experiences of integration of clinical systems through standards with open technologies.
...
Apr 26
SCADA system for electricity supply in the National Center for Biopreparations
...
Apr 26
Design of an automated system for critical supplies of a Quality Control laboratory in the biopharmaceutical industry.
...
Apr 26
Mejoras en el sistema automático de monitoreo continuo de partículas en áreas limpias de las Plantas de Parenterales de BIOCEN
...
Apr 26
Improvements in the automatic system for continuous monitoring of particles in clean areas of the BIOCEN Parenteral Plants.
...
Apr 26
Desafiando los paradigmas existentes en la terapia del cáncer
...
Apr 26
First steps in Industry 4.0 of Suma technology
...
Apr 26
IncuBIO: A Special Purpose Vehicle to funnel venture capital investment into Cuban biotech assets.
...
Apr 26
High Tech Joint Venture Enterprise for the Grain Seed Production.
...
Apr 26
National Design and implementation of an electronic prescription system in Belgium
...
Apr 26
Potential for the application of telemedicine in the export of cuban medical services. The case of the medical mission in Qatar
...
Apr 26
“Improving down-stream protein production.”
...
Apr 26
“Process Control of Continuous Bioprocesses”
...
Apr 26
Development and industrial scale-up of the first conjugate vaccine against SARS-CoV-2: Soberana 02
...
Apr 27
The senescent immune system as a key driver of aging
...
Apr 27
Cell senescence as a driver of chronic inflammation in ageing
...
Apr 27
Global virus outbreaks: interferons- as first line therapeutics
...
Apr 27
Interferon-gamma: When a good cytokine goes bad
...
Apr 27
Itolizumab in the treatment of patients with COVID-19: Cuban experience
...
Apr 27
How the past can determine your future: can we reverse the epigenetic clock age to promote healthy aging?
...
Apr 27
Structural biology for vaccine development: the example of SOBERANA vaccines
...
Apr 27
Targeting senescence for healthy aging
...
Apr 27
Open label phase I/II clinical trial and predicted efficacy of SARS-CoV-2 RBD protein vaccines SOBERANA 02 and SOBERANA Plus in children
...
Apr 27
Vaccination of convalescent children: Open label phase I/II clinical trial with a single doses of SOBERANA Plus
...
Apr 27
Anti-aging effect of Cuban policosanol via enhancement of anti-inflammatory effect in high-density lipoproteins
...
Apr 27
Molecular mechanisms of dietary restriction promoting health and longevity
...
Apr 27
Vulnerability management in OT environments.
...
Apr 27
Smart Company: Business automation for climated-based energy savings.
...
Apr 27
IC NEURONIC S.L. Experience in the production and certification of medical devices in Europe.
...
Apr 27
“CHO cell line engineering using  mirna and rapid screening of high producing clones”
...
Apr 27
“Magnetic bioseparation, biotechnological industry processes and nanoparticles as separation supports”
...
Apr 27
“Magnetic bioseparation, biotechnological industry processes and nanoparticles as separation supports”
...
Apr 27
Posibilities of early detection of tumors through bioimpedance measurements
...
Apr 28
Obesity accelerates age-associated human B cell defects: role of the adipose tissue
...
Apr 28
Efficacy and Preclinical Safety of vaccine candidates to SARS-CoV-2 (SOBERANA® Vaccines)
...
Apr 28
Chimeric antigen produced in HEK-293 cells, based on SARS-CoV2 nucleoprotein fused to the extracellular domain of human CD154, induced high immunogenicity in mice and non-human primates
...
Apr 28
Targeting of protein kinase CK2 in Acute Myeloid leukemia cells using the Clinical-Grade synthetic-peptide CIGB-300
...
Apr 28
Abexol: anti-inflammatory of natural origin for the management of symptoms in patients with osteoarthritis
...
Apr 28
Abdala vaccine against SARS-CoV-2 induces functional antibodies in rats and cynomolgus monkeys
...
Apr 28
Longitudinal study of the immune response generated against SARS-CoV-2 infection in Cuban COVID-19 recovered patients
...
Apr 28
BioManguinhos-BioCubaFarma Alliance: Successful experience in South-South collaboration in biotechnology.
...
Apr 28
CIM-CIMAB Alliance, thirty years of commercial experiences.
...
Apr 28
Cybersecurity
...
Apr 28
Quality 4 and its potential impact on the Cuban biotechnological, pharmaceutical and medical technology industry
...
Apr 28
Technology transfer and scaling of the production of biotechnological products and vaccines against COVID-19 in BioCen.
...
Apr 28
Proposal for the evaluation of transversal skills in the management of the software process from the Computer Sciences.
...
Apr 29
Immune Ageing: Focus on Sicilian ultra-centenarians
...
Apr 29
Implications of Immunosenescence for Immunization of Older Adults
...
Apr 29
Analysis of the landscape of medicines for the treatment of diseases of the elderly in Russia and the prospects for their increase
...
Apr 29
Association of chronic neurological diseases with clinical phenotypes of patients with COVID-19 in intensive care units
...
Apr 29
Jusvinza, an anti-inflammatory drug derived from the human heat-shock protein 60, for critically ill COVID-19 patients. An observational study
...
Apr 29
Evaluation and use of UMELISA SARS-CoV-2 ANTI RBD in immunogenicity studies of individuals immunized with the Abdala and Soberana vaccines
...
There are no activities
scheduled for today.
Everyone

You may also be interested

Special Sessions
My Agenda
Sponsorship
Finlay institute of vaccines signs a memorandum of understanding with an Italian company for the production of Soberana 02
29/ 4/ 22, 11:26 AM
An agreement to start the production of the Sovereign 02 vaccine in the final stages in Italy was signed today between the Finlay Institute of Vaccines (IFV), the Italian company ADIENNE Pharma & Biotech and the Italian Agency for economic and cultural exchange with Cuba (AICEC). ), in the context of the BioHabana 2022 congress. […]
visitar
Cuban vaccine against lung cancer centers scientific collaboration between the CIM and the Roswell Park Institute, New York
29/ 4/ 22, 11:16 AM
The Cuban vaccine against lung cancer, CIMAvax-EGF®, developed by the Center for Molecular Immunology (CIM), continues to expand its horizons both in therapeutic indications and in scientific collaboration, while remaining the core of joint research between the CIM and the Roswell Park Institute, New York, in the United States. This was confirmed to Cubadebate by […]
visitar
ETI Solution for information management of Immunological Studies
29/ 4/ 22, 10:57 AM
visitar
International Immunology Day
29/ 4/ 22, 10:43 AM
Immunology is a SPECIALTY of multidisciplinary scope, which transits through health prevention through immunization, diagnosis and highly specialized medical care. It is a fundamental tool when undertaking first-class biomedical research projects, whose results provide new knowledge and generate effective and innovative products and technologies. In general, immunologically-based diseases are of progressive course, in many cases […]
visitar
NeuroEPO advances in favor of memory
29/ 4/ 22, 10:31 AM
One of the most promising products that the Center for Molecular Immunology (CIM) has today is NeuroEPO, a neuroprotective drug that was obtained last March by the Cuban regulatory agency, the Center for State Control of Medicines, Equipment and Medical Devices (Cecmed) a conditional health registration for the indication of mild and moderate Alzheimer’s disease. […]
visitar
Clinical study with Mambisa in convalescents: Antibody titers increased at least fourfold in most subjects
28/ 4/ 22, 12:53 PM
Dr. Gerardo Guillén Nieto, director of Biomedical Research at the Center for Genetic Engineering and Biotechnology (CIGB), reported that the study included 1,041 convalescent volunteers with at least two months of recovery and up to more than a year and a half of having contracted the disease. It had two research arms: one where half of the sample received the Abdala vaccine, and the other half a single booster dose of the Mambisa vaccine candidate.
visitar
Infantix, the system developed by CNEURO for the detection of hearing and vision disorders
28/ 4/ 22, 9:12 AM
For the first time in the context of neonatal screening, a system allows recording of visual evoked potentials, providing an objective assessment of the visual pathway in a few minutes. This same system is aimed at the objective detection of hearing disorders through the recording and analysis of automatic brainstem auditory evoked potentials and otoacoustic emissions. Its features also make it possible to differentiate between transient and permanent conductive losses due to neural damage.
visitar
Prime Minister of Dominica highlights what Cuban biotechnology could achieve without the blockade
28/ 4/ 22, 8:58 AM
Roosevelt Skerrit, Prime Minister of the Commonwealth of Dominica, visited the BioHabana 2022 trade fair this afternoon at the Havana Convention Center, where he received information on the products of the Cuban biotechnology industry. He was particularly interested in the Cuban vaccines against COVID-19, developed and produced in the country, and which have allowed in a short time to advance in the immunization of the Cuban population.
visitar
Minister of Health: “The best responses to combat COVID-19 have been born from science”
27/ 4/ 22, 5:20 PM
“Covid-19 has represented the greatest challenge for science in recent decades. Never before have so many scientists, professionals, and experts investigated the same topic so intensely and in such a short period of time,” said the Minister of Health, José Angel Portal Miranda, in a keynote address during BioHabana 2022. “Cuba has not been the […]
visitar

Social media